+1 915 229 3004 (U.S.) | 
+44 7452 242832 (U.K.)
+1 915 229 3004 (U.S.) | +44 7452 242832 (U.K.)
Anthelmintics are medications designed to treat parasitic worm infestations in animals, including both flat and roundworms such as flukes and tapeworms. These drugs inhibit metabolic activities essential to parasites without harming the host. The market analysis by Research Layer indicates that the global anthelmintics market reached USD 2,846.91 million in 2021 and is projected to reach USD 5,435.61 million by 2029, with a Compound Annual Growth Rate (CAGR) of 8.45% from 2022 to 2029.
1. Drug Class: The market is segmented by drug class, including Benzimidazoles and Piperazine.
2. Target Pathogen: Target pathogens for anthelmintics include Ancylostoma Duodenale, Ascaris Lumbricoides, Enterobius Vermicularis, and Trichuris Trichiura.
3. Drugs: Various drugs in the market include Miltefosine, Thiabendazole, Praziquantel, Mebendazole, Albendazole, Pyrantel, Ivermectin, and others.
4. Application: Anthelmintics are used to treat conditions like Angiostrongylosis, Ascariasis, Capillariasis, Echinococcus, Gnathostomiasis, Liver Fluke, Moniliformis Infection, Trichostrongylosis, Enterobiasis, among others.
5. Route of Administration: Anthelmintics can be administered orally, parenterally, or through other routes.
6. End-Users: Anthelmintics are utilized in various settings, including Hospitals, Specialty Clinics, Homecare, and others.
7. Distribution Channel: The drugs reach end-users through channels like Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, and others.
1. North America: Dominates the market share and revenue, driven by a growing prevalence of helminth infections and increased healthcare expenditure.
2. Asia-Pacific: Expected to be the fastest-growing region due to a rising geriatric population, developing healthcare infrastructure, and government initiatives.
· Increasing prevalence of helminth infections.
· Rise in healthcare expenditure, improving infrastructure.
· Government initiatives and a shift in focus toward managing helminth infections.
· Growth in the number of clinical trials and strategic collaborations.
· Rising number of clinical trials in AI-driven drug development.
· Strategic collaborations for new treatments.
· Increasing research and development activities and emerging markets.
· High cost of drug development.
· Lack of healthcare infrastructure in developing economies.
· Dearth of skilled professionals.
· Lack of awareness and potential side effects of drugs.
The COVID-19 outbreak significantly affected the anthelmintics market, causing drug shortages and unavailability in healthcare facilities. Production facility shutdowns, export restrictions, increased demand for COVID-19 treatments, and disruptions in the supply chain had substantial impacts.
Zoetis received FDA approval for Simparica Trio, a once-monthly, chewable tablet providing all-in-one protection from heartworm disease, roundworm ticks, fleas, and hookworms.
F. Hoffmann-La Roche Ltd., Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Pfizer Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Merck & Co., Inc., Allergan, AstraZeneca, Johnson & Johnson Private Limited, Cipla Inc., Amneal Pharmaceuticals LLC., Merck KGaA, Mankind Pharma, Zydus Cadila, GALDERMA, Zoetis, and Boehringer Ingelheim International GmbH.
This comprehensive market report provides insights into market trends, growth factors, segmentation, regional analysis, and competitive landscape, aiding stakeholders in making informed decisions for market growth. For more detailed information, contact Data Bridge Market Research for an Analyst Brief.
the global anthelmintics market reached USD 2,846.91 million in 2021 and is projected to reach USD 5,435.61 million by 2029.
The global market is projected to grow at a CAGR of 8.45% during the forecast period, 2023-2029.
Research on the market is done by industry professionals who provide personalized insights on the industry structure, market segmentation, Type assessment, competitive landscape (CL), along with penetration, and emerging trends. In addition to years of professional experience in their various fields and sectors, their analysis is largely based on primary interview (60%) and secondary research (40%) as well as years of professional experience. In addition, our researchers forecast the market's direction over the following seven years by examining past trends and the market's current position. Additionally, various trends of segments and categories that are geographically portrayed are studied and estimated using primary and secondary research.
The key level executives (VP, CEO, Marketing Directors, and Business Development Managers) of the major industry participants who are active and prominent as well as mid-scale businesses operating in this market were interviewed in-depth for this supply-side report by overall Global Market Research.
Extensive primary research was conducted to gain a deeper grasp of the market and industry. Both primary and secondary research, as well as years of pertinent professional experience, are used to support the analysis. By analyzing past and present market patterns, our experts were able to forecast the market's course over the following seven years. For the geographically offered categories in the list of market tables, it differs per category. In connection with the Global Market research report, we also conducted a number of primary interviews with senior level executives (VP, CEO's, Directors, Marketing Directors, Business Development Managers, CFOs, Technical Consultants, Key Opinion Leaders, Industry Experts, Decision Matrix Authorities, and other crucial individuals) of the key industry players who dominated the Global market.
The primary purpose of secondary research was to gather, identify, and validate the information necessary for the thorough, technical, market-focused, and commercial analysis of the global market. With the use of this study, it was also possible to classify and segment the market in accordance with market trends, geographic markets, and regional considerations linked to market type. Analysts have gathered data in the Distribution Channel for the study of the market from reliable sources including annual reports, journals, white papers, corporate presentations, company websites, international organizations of Energy and Power manufacturers, credible paid databases, and many others to gather reliable intel.
Both top-down and bottom-up methodologies were employed to assess the accuracy of the global market size. The market for as a whole was estimated using these methods for a number of different dependent submarkets. Secondary research was used to address the major industry players, and primary and secondary research was used to calculate their market shares in the various regions. This complete intellectual process includes reading the annual and financial reports of the top market participants and conducting in-depth interviews with top industry executives (VP, CEO, Marketing Directors, and Business Development Managers) to gain important industry insights.
Through reliable secondary sources and validated primary sources, the classification of the global markets and their geographic percentage splits were established. To obtain the final qualitative and quantitative data, all relevant variables that might have an impact on the market under investigation have been taken into consideration, inspected in great depth, verified through primary research, and assessed. This information was collected, added to, and thoroughly examined by professional analysts before being provided in this report. The process used to estimate the overall market size for this study is depicted in the following image as an example.
Report Code :
RL65442
Published on :
Upcoming
Request a Free Sample Report
Speak to Analyst